Paper41375813
When Blood Disorders Meet Cancer: Uncovering the Oncogenic Landscape of Sickle Cell Disease.
Casadessus E and 5 others. J Clin Med, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. When Blood Disorders Meet Cancer: Uncovering the Oncogenic Landscape of Sickle Cell Disease. Papers, record 41375813. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41375813
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- When Blood Disorders Meet Cancer: Uncovering the Oncogenic Landscape of Sickle Cell Disease.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References143
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36551957 | Case Report of Myelodysplastic Syndrome in a Sickle-Cell Disease Patient Treated with Hydroxyurea and Literature Review. | Biomedicines | 2022 | https://conductscience.org/library/papers/36551957 | PubMed |
| 2 | 30218578 | Effects of hydroxyurea on CNV induction in the mouse germline. | Environ Mol Mutagen | 2018 | https://conductscience.org/library/papers/30218578 | PubMed |
| 3 | 25203083 | Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. | JAMA | 2014 | https://conductscience.org/library/papers/25203083 | PubMed |
| 4 | 29974957 | Potential involvement of ubiquitin-proteasome system dysfunction associated with oxidative stress in the pathogenesis of sickle cell disease. | Br J Haematol | 2018 | https://conductscience.org/library/papers/29974957 | PubMed |
| 5 | 32161723 | Bone Marrow Senescence and the Microenvironment of Hematological Malignancies. | Front Oncol | 2020 | https://conductscience.org/library/papers/32161723 | PubMed |
| 6 | 28830890 | Increased risk of leukemia among sickle cell disease patients in California. | Blood | 2017 | https://conductscience.org/library/papers/28830890 | PubMed |
| 7 | 32437728 | Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives. | Immunol Lett | 2020 | https://conductscience.org/library/papers/32437728 | PubMed |
| 8 | 32855279 | Fetal hemoglobin rescues ineffective erythropoiesis in sickle cell disease. | Haematologica | 2021 | https://conductscience.org/library/papers/32855279 | PubMed |
| 9 | 22918118 | DNA damage in leukocytes of sickle cell anemia patients is associated with hydroxyurea therapy and with HBB*S haplotype. | Mutat Res | 2012 | https://conductscience.org/library/papers/22918118 | PubMed |
| 10 | 29542687 | Sickle cell disease. | Nat Rev Dis Primers | 2018 | https://conductscience.org/library/papers/29542687 | PubMed |
| 11 | 25426838 | Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25426838 | PubMed |
| 12 | 28587497 | Accelerated leukemic transformation after haplo-identical transplantation for hydroxyurea-treated sickle cell disease. | Leuk Lymphoma | 2018 | https://conductscience.org/library/papers/28587497 | PubMed |
| 13 | 28577651 | Telomere length correlates with disease severity and inflammation in sickle cell disease. | Rev Bras Hematol Hemoter | 2017 | https://conductscience.org/library/papers/28577651 | PubMed |
| 14 | 31693163 | Intestinal pathophysiological and microbial changes in sickle cell disease: Potential targets for therapeutic intervention. | Br J Haematol | 2020 | https://conductscience.org/library/papers/31693163 | PubMed |
| 15 | 28803919 | Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. | Cell Stem Cell | 2017 | https://conductscience.org/library/papers/28803919 | PubMed |
| 16 | 31880407 | Haploidentical bone marrow transplantation in a patient with sickle cell disease and acute myeloid leukemia. | Pediatr Transplant | 2020 | https://conductscience.org/library/papers/31880407 | PubMed |
| 17 | 18485083 | Delayed adverse vascular events after splenectomy in hereditary spherocytosis. | J Thromb Haemost | 2008 | https://conductscience.org/library/papers/18485083 | PubMed |
| 18 | 4502362 | Frequency and prognosis of coexisting sickle cell disease and acute leukemia in children. | Clin Pediatr (Phila) | 1972 | https://conductscience.org/library/papers/4502362 | PubMed |
| 19 | 23746838 | The hallmarks of aging. | Cell | 2013 | https://conductscience.org/library/papers/23746838 | PubMed |
| 20 | 17645642 | Sickle cell disease: role of reactive oxygen and nitrogen metabolites. | Clin Exp Pharmacol Physiol | 2007 | https://conductscience.org/library/papers/17645642 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42194209 | Should Sickle Cell Disease Be Considered a Cancer Predisposition Syndrome? | Children (Basel) | 2026 | https://conductscience.org/library/papers/42194209 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41375813
GET https://conductscience.org/api/papers/v1/41375813/references?page=2